Variable | 5-year DFS rate | 5-year OS rate | ||||
---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | ||||
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
Age (> 60 vs. ≤ 60 years) | 0.545 (0.249–1.194) | 0.129 |  |  | 0.862 (0.425–1.748) | 0.681 |
Sex (male vs. female) | 0.878 (0.460–1.677) | 0.694 |  |  | 0.758 (0.397–1.444) | 0.399 |
DAV (≤ 5 cm vs. > 5 cm) | 0.698 (0.361–1.315) | 0.259 |  |  | 0.834 (0.488–1.783) | 0.834 |
pT stage (3–4 vs. 0–2) | 2.940 (1.344–6.434) | 0.007 | 2.242 (0.987–5.093) | 0.054 | 2.365 (1.115–5.018) | 0.025 |
pN stage (1–2 vs. 0) | 2.903 (1.519–5.546) | 0.001 | 2.281 (1.157–4.495) | 0.017 | 1.801 (0.939–3.453) | 0.076 |
Type of resection (LAR vs. APR) | 0.983 (0.485–1.989) | 0.961 |  |  | 0.693 (0.356–1.348) | 0.280 |
Perioperative chemotherapy cycles (≤ 6 vs. > 6) | 2.124 (0.971–4.646) | 0.059 |  |  | 1.381 (0.682–2.798) | 0.370 |
Treatment (CCRT + TME vs. TME) | 1.030 (0.540–1.963) | 0.929 |  |  | 0.887 (0.461–1.707) | 0.720 |